T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
726
Nebius Group N.V.
NBIS
$65.8B
| $57.5M | 0.01% |
2,633,193
-941,000
| -26% | -$18.3M |
|
|
ELME
727
Elme Communities
ELME
$144M
| $57.2M | 0.01% |
1,819,419
-1,651
| -0.1% | -$48.7K |
|
728
Hewlett Packard
HPE
$77.8B
| $56.9M | 0.01% |
5,362,949
-46,994
| -0.9% | -$478K |
|
729
Dollar Tree
DLTR
$24.7B
| $56.9M | 0.01% |
603,276
+12,890
| +2% | +$1.09M |
|
|
NILE
730
DELISTED
Blue Nile, Inc.
NILE
| $56.8M | 0.01% |
2,076,289
| – | – |
|
731
Carpenter Technology
CRS
$26.3B
| $56.8M | 0.01% |
1,724,150
-223,310
| -11% | -$7.44M |
|
|
UNVR
732
DELISTED
Univar Solutions Inc.
UNVR
| $56.7M | 0.01% |
2,996,541
+444,180
| +17% | +$8.07M |
|
|
WBT
733
DELISTED
Welbilt, Inc.
WBT
| $56.6M | 0.01% |
3,211,517
+3,034,014
| +1,709% | +$48.3M |
|
734
Brady Corp
BRC
$4.48B
| $56.5M | 0.01% |
1,848,870
-66,700
| -3% | -$1.93M |
|
|
FNFG
735
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $56.4M | 0.01% |
5,785,607
-70,321
| -1% | -$724K |
|
736
Green Dot
GDOT
$766M
| $56.3M | 0.01% |
2,450,060
-67,467
| -3% | -$1.5M |
|
|
DNKN
737
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $56.2M | 0.01% |
1,288,664
-50,635
| -4% | -$2.31M |
|
738
Mueller Water Products
MWA
$4.09B
| $56M | 0.01% |
4,905,011
+230,494
| +5% | +$2.46M |
|
739
Aaon
AAON
$7.03B
| $55.5M | 0.01% |
3,027,921
+34,515
| +1% | +$624K |
|
740
Innospec
IOSP
$2.29B
| $55.1M | 0.01% |
1,198,955
-146,480
| -11% | -$6.93M |
|
|
AVP
741
DELISTED
Avon Products, Inc.
AVP
| $55M | 0.01% |
14,555,074
-1,315,104
| -8% | -$5.66M |
|
742
Blackbaud
BLKB
$2.03B
| $54.8M | 0.01% |
807,437
+156,577
| +24% | +$9.89M |
|
743
Ryanair
RYAAY
$30.8B
| $54.8M | 0.01% |
1,970,480
-224,045
| -10% | -$7.27M |
|
|
SNV
744
DELISTED
Synovus
SNV
| $54.6M | 0.01% |
1,883,564
-9,968
| -0.5% | -$303K |
|
745
Forum Energy Technologies
FET
$932M
| $54.6M | 0.01% |
157,705
-972
| -0.6% | -$311K |
|
|
EQY
746
DELISTED
Equity One
EQY
| $54.6M | 0.01% |
1,695,185
-16,091
| -0.9% | -$471K |
|
747
Energizer
ENR
$1.56B
| $54.4M | 0.01% |
1,056,397
+1,610
| +0.2% | +$73.7K |
|
|
CVT
748
DELISTED
CVENT, INC.
CVT
| $54.2M | 0.01% |
1,518,124
-1,800,897
| -54% | -$59.7M |
|
749
Saia
SAIA
$9.73B
| $54M | 0.01% |
2,149,489
+118,039
| +6% | +$3.14M |
|
|
FPO
750
DELISTED
First Potomac Realty Trust
FPO
| $54M | 0.01% |
5,870,024
+71,622
| +1% | +$638K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.